Get alerts for new trials in your area by subscribing now
Peanut allergy causes more fatal allergic reactions than any other food allergy, largely because peanut protein is potent and exposure is hard to fully avoid in daily life. Reactions can escalate quickly to anaphylaxis, which is why most peanut allergy trials build in extensive safety monitoring, including on-site observation after each dose.
Peanut allergy trials generally fall into a few groups. Oral immunotherapy trials have participants eat small, gradually increasing amounts of peanut protein under medical supervision. Others test a skin patch delivery method, still investigational and not yet FDA approved, that exposes the immune system to peanut protein without ingestion. Antibody-based trials test whether blocking the allergic signal directly can protect against reactions instead of building tolerance to peanut specifically.
Yes. People with allergic asthma face a higher risk of severe or fatal anaphylaxis from peanut exposure, since poorly controlled asthma makes breathing complications during a reaction more dangerous. Allergists often manage both conditions together for this reason.
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything.
Curious whether clinical trials pay participants? Here's how compensation actually works.
Search the studies on this page for ones that match your child's or your own age and allergy history. A study coordinator will follow up to walk through eligibility, often including a review of prior allergy testing.